These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9425286)
41. Vitamins D: Relationship between Structure and Biological Activity. Kutner A; Brown G Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037036 [TBL] [Abstract][Full Text] [Related]
42. The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer Agent. Marcinkowska E; Wallace GR; Brown G Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187375 [TBL] [Abstract][Full Text] [Related]
43. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C. Zheng R; Wang X; Studzinski GP J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741 [TBL] [Abstract][Full Text] [Related]
44. Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs. Marchwicka A; Cebrat M; Sampath P; Snieżewski L; Marcinkowska E Front Oncol; 2014; 4():125. PubMed ID: 24904835 [TBL] [Abstract][Full Text] [Related]
45. Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability. Gocek E; Baurska H; Marchwicka A; Marcinkowska E Leuk Res Treatment; 2012; 2012():713243. PubMed ID: 23213549 [TBL] [Abstract][Full Text] [Related]
46. PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling. Maier CJ; Maier RH; Rid R; Trost A; Hundsberger H; Eger A; Hintner H; Bauer JW; Onder K BMC Mol Biol; 2012 Jun; 13():18. PubMed ID: 22720752 [TBL] [Abstract][Full Text] [Related]
47. Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells. Wang X; Studzinski GP J Cell Physiol; 2011 May; 226(5):1232-40. PubMed ID: 20945381 [TBL] [Abstract][Full Text] [Related]
48. Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy. Hughes PJ; Marcinkowska E; Gocek E; Studzinski GP; Brown G Leuk Res; 2010 May; 34(5):553-65. PubMed ID: 19811822 [TBL] [Abstract][Full Text] [Related]
49. Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway. Chen BC; Chang HM; Hsu MJ; Shih CM; Chiu YH; Chiu WT; Lin CH J Biol Chem; 2009 Jul; 284(31):20562-73. PubMed ID: 19531467 [TBL] [Abstract][Full Text] [Related]
50. Activation of rapid signaling pathways does not contribute to 1 alpha,25-dihydroxyvitamin D3-induced growth inhibition of mouse prostate epithelial progenitor cells. Li J; Fleet JC; Teegarden D J Cell Biochem; 2009 Aug; 107(5):1031-6. PubMed ID: 19492419 [TBL] [Abstract][Full Text] [Related]
51. Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds. Kim SH; Danilenko M; Kim TS Br J Pharmacol; 2008 Nov; 155(6):814-25. PubMed ID: 18724384 [TBL] [Abstract][Full Text] [Related]
52. Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module. Wang X; Studzinski GP J Cell Physiol; 2006 Nov; 209(2):253-60. PubMed ID: 16883571 [TBL] [Abstract][Full Text] [Related]
53. Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Marcinkowska E; Garay E; Gocek E; Chrobak A; Wang X; Studzinski GP Exp Cell Res; 2006 Jul; 312(11):2054-65. PubMed ID: 16624284 [TBL] [Abstract][Full Text] [Related]
55. Enhancement of 1 alpha,25-dihydroxyvitamin D(3)-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity. Kang SN; Kim SH; Chung SW; Lee MH; Kim HJ; Kim TS Br J Pharmacol; 2002 Mar; 135(5):1235-44. PubMed ID: 11877332 [TBL] [Abstract][Full Text] [Related]
56. 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. Hmama Z; Nandan D; Sly L; Knutson KL; Herrera-Velit P; Reiner NE J Exp Med; 1999 Dec; 190(11):1583-94. PubMed ID: 10587349 [TBL] [Abstract][Full Text] [Related]
57. 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Marcinkowska E; Wiedłocha A; Radzikowski C Biochem Biophys Res Commun; 1997 Dec; 241(2):419-26. PubMed ID: 9425286 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells. Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364 [TBL] [Abstract][Full Text] [Related]
59. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160 [TBL] [Abstract][Full Text] [Related]
60. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway. Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]